Wilmer Cutler Pickering Hale and Dorr represented Agios Pharmaceuticals, Inc. in the deal. Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation...
Agios Pharmaceutical’s $905 Million Purchase Agreement for Vorasidenib Royalty
Agios’s $345 Million Repurchase Agreement With Bristol-Myers Squibb Company
Wachtell, Lipton, Rosen & Katz advised Agios Pharmaceuticals on the deal. Agios Pharmaceuticals, Inc. entered into a Share Repurchase Agreement with Bristol-Myers Squibb Company, pursuant to...